Abstract:Objective:To explore the effect of the acute treatment outcome on the trajectory of residual symptoms for major depressive disorder (MDD).Method:This is a multicenter, prospective, non-intervention study. The MDD patients who self-reported an improvement after received an 8-12 weeks antidepressant treatment were included. Social-demographic and clinical characteristics were collected at the baseline. Brief 16-item Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR 16), Generalized Anxiety Disorder Scale (GAD-7), Arizona Sexual Experience Scale experience (ASEX), Digital Span Test (DST) and Digit Symbol Substitution Test (DSST) were used to assess the symptoms. Patients were followed up at month 1, 3 and 6. Mix effect model and generalized estimating equation were used to analysis changes over visits of symptoms within or between groups. Result:Totally, 428 eligible patients were included in this study. At baseline, 179 patients achieved remission (41.8%,179/428) and 249 achieved partial remission (58.2%,249/428). There were no significant differences in demographics, clinical characteristics and treatment between the two groups. The proportion of increased appetite, weight gain, suicidal ideation, and restlessness in the remission group did not change significantly over time ( Z=-1.62-1.34, all P>0.003), meanwhile, the proportion of hypersomnia, increased appetite, and weight gain in the partial remission group did not change significantly over the course of the assessments ( Z=-2.43- -1.26, all P>0.003). The proportion of other residual symptoms changed significantly from baseline to 6-month follow-up in both groups ( Z=-10.77- -2.46, all P<0.003), nevertheless, there was no significant difference between the two groups ( Z=0.37-3.26, all P>0.003). The total score of GAD-7 of the two groups were significantly different at each assessment timepoint (χ 2=24.68-113.80, P<0.01), and the improvement of anxiety in the remission group was better than that in the partial remission group ( F=8.39, P<0.01). There were no significant differences in the total ASEX scores between the two groups at each visit ( F=-1.93- -0.68, all P>0.05), and there were no significant difference within the group ( F=0.01-0.17, P>0.05). There was no significant difference in the total scores of DST and DSST between the two groups at baseline ( F=-1.23, -1.14, all P>0.05), and also no significant differences were found during all follow-up visits after control for score at baseline ( F=-1.14- -0.91, all P>0.05). Conclusions:The treatment outcome of the acute phase has an impact on the residual symptoms of MDD. Remission has a positive effect on the improvement of anxiety, but has no significant effect on the improvement of sexual dysfunction and cognitive function.

The quality of life in depressed outpatients: 6-month follow-up study

A preliminary study of quality of life in patients with type 2 diabetes mellitus coexisting major depression

A Preliminary Study of Quality of Life in Patients with Treatment Resistant Depression

Quality of Life in Outpatients with Depression in China.

Investigation of quality of life in elderly and middle-aged patients with chronic diseases in community outpatient clinic

The Medical Cost of Depressed Outpatients in Shanghai and 6-month Follow-up Study with Treatment of Paroxetine

Effects of treatment outcome in acute phase of depression on residual symptoms in a 6-month follow-up: a national, multicenter study

Quality of life in patients with acute coronary syndrome combined anxiety and depressive symptoms

Quality of life in Parkinson's disease: A prospective 3-year study

Comparative Study on Quality of Life of Schizophrenics treated with Risperidone or Clozapine

Long-term influence of mental intervention on quality of life in senile depression patients

Comparison of Residual Depressive Symptoms, Functioning, and Quality of Life Between Patients with Recurrent Depression and First Episode Depression After Acute Treatment in China.

Longitudinal trajectory of the association between quality of life and depression among people living with HIV in China: a mixed effects model

Socio-Demographic and Clinical Determinants of Quality of Life in Chinese Patients with Schizophrenia: A Prospective Study

The Effective Study of Supportive Psychological Intervention on the Quality of Life of the Depressed Elderly

A National Survey of Residual Symptoms in Chinese Depressive Patients after Acute Phase Treatment

The investigation on psychological status and quality of life for HIV/AIDS patients in Minhang District of Shanghai

A Pilot Study on Quality of Life in Obsessive-Compulsive Disorder

Prevalence of depressive syndrome and quality of life in out-patients of neurology department in 2 general hospitals

Investigation of the Health-related Quality of Life and Psychoactive Status of Patients with Stable COPD

A Follow-Up Study on the Effect of Novel Antidepressants on Life Satisfaction of Major Depression Patients